Graph Revisionism

Graph Revisionism I applaud Sam Jaffe's efforts to improve scientific data presentation.1 However, his statement that "bar graphs are a universal no-no" is not warranted. Worse yet, his suggested remedy is flawed. He suggests using line graphs to illustrate categorical data instead of bar graphs. The problem is that line graphs are based on the assumption that the data are continuously variable, unless there are breaks in the X axis. Also, points on a line graph do not solve his basic o

Written byWr Klemm
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I applaud Sam Jaffe's efforts to improve scientific data presentation.1 However, his statement that "bar graphs are a universal no-no" is not warranted. Worse yet, his suggested remedy is flawed. He suggests using line graphs to illustrate categorical data instead of bar graphs. The problem is that line graphs are based on the assumption that the data are continuously variable, unless there are breaks in the X axis. Also, points on a line graph do not solve his basic objection to bar graphs, which was that bar graphs emphasize "the size of the columns, whereas the only point that's important is the top of the bar." A line graph of the same data has the same problem: the only point that is important is the height of the data points, not the lines. The lines actually misrepresent reality.

I vote for histograms. Pie charts are an alternative, but then he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies